Another Day, Another Deal: What to Watch from AbbVie, Allergan, Micron, Buffett

What ever happened to Merger Monday? 

Action Alerts PLUS senior analyst Jeff Marks and research analyst Zev Fima are breaking down everything you need to know about the markets from AbbVie's (ABBV - Get Report) $63 billion takeover of Allergan (AGN - Get Report) to Warren Buffett's comments on Kraft Heinz (KHC - Get Report) . 

Jim Cramer and Katherine Ross have the morning off. 

Is the Price Right for Allergan? 

Wall Street woke up to news of yet another major corporate takeover. AbbVie will pay $188.24 per share in cash and stock for Allergan in a $63 billion takeover, marking a 45% premium over Allergan's most recent closing price. 

While Abbvie said the deal will add 10% to the combined group in the first year with products including Botox, it's certainly paying quite the price for Allergan; is it too much? Jeff Marks breaks it down. 

How to Avoid Paying Too Much for Ketchup

The Oracle of Omaha is in the headlines again after making comments on Kraft Heniz to CNBC. While pledging his confidence in incoming CEO Miguel Patricio, Warren Buffett conceded that he paid too much for Kraft and acknowledged the difficulties stemming from his 26.7% stake in the group. 

Even Buffett makes mistakes and it's important to learn from them. Marks breaks down 3 signs you could be overpaying for a stock. 

What to Expect from Micron

Micron (MU - Get Report) is set to report earnings after the bell June 25. On average, analysts polled by FactSet expect Micron to report revenue of $4.69 billion and non-GAAP earnings per share of $0.79. 

Having shed nearly all of its 2019 gains over the past two months on trade concerns and declining memory prices, investors will be going through the report with a fine-toothed comb. 

Marks reveals the most important thing to listen for in the chipmaker's earnings call. 

Related. AbbVie Fizzles, Gold, Bitcoin and (Some) Biotech Sizzles

A Bit About Today's Host, Zev Fima

N/A